MDM2 and cancer: Genetic studies demonstrate that mutation of MDM2 (C305F), impairing the ribosomal stress signaling [4] and mutation of MDMX (3SA), impairing the DNA damage signaling [115], can lead to defects of lipid and glucose metabolisms in cancer cells [1,116].